Donald Hooker
Stock Analyst at Keybanc
(2.49)
# 2,369
Out of 5,116 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $5.45 | +1,734.86% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $210.48 | +85.29% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $187.03 | -9.11% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $230.15 | +26.00% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $13.43 | +443.56% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $4.19 | +759.19% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $4.55 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $203.92 | +73.11% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $85.59 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $94.44 | -11.05% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.21 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $271.52 | -37.39% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $180.25 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $0.92 | +4,883.75% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $582.48 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $5.45
Upside: +1,734.86%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $210.48
Upside: +85.29%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $187.03
Upside: -9.11%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $230.15
Upside: +26.00%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $13.43
Upside: +443.56%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $4.19
Upside: +759.19%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $4.55
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $203.92
Upside: +73.11%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $85.59
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $94.44
Upside: -11.05%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $3.21
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $271.52
Upside: -37.39%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $180.25
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $0.92
Upside: +4,883.75%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $582.48
Upside: -